Source: Eyewire News

UNITY: Unity Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in DME

Unity Biotechnology announced topline results from the phase 2b ASPIRE clinical trial of intravitreal UBX1325 in patients with diabetic macular e

Read full article »
UNITY's Competitors | UNITY's News | UNITY's Financials
Stay up-to-date with the latest news on UNITY
Annual Revenue
$100K-5.0M
Employees
1-25
Anirvan Ghosh's photo - CEO of UNITY

CEO

Anirvan Ghosh

CEO Approval Rating

58/100

Read more
Stay up-to-date with the latest news on UNITY